Saxenda (liraglutide) is another GLP-1 receptor agonist approved ... In a year-long study funded by Saxenda’s manufacturer, Novo Nordisk, people without diabetes who took Saxenda lost an average of 18 ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Every earnings season has its share of outperformers, companies that report blowout quarters and raise their forecasts. The ...